US Taxpayers Heavily Funded the Discovery of COVID-19 Vaccines.

Lalani, Hussain S; Avorn, Jerry; Kesselheim, Aaron S

Lalani, Hussain S; Avorn, Jerry; Kesselheim, Aaron S.

Lalani HS; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Avorn J; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Kesselheim AS; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Clin Pharmacol Ther ; 111(3): 542-544, 2022 03.

Article in English | MEDLINE | ID: covidwho-1303245

Subject(s)

COVID-19 Vaccines/economics; Financing, Government; 2019-nCoV Vaccine mRNA-1273/economics; Financing, Organized; Intellectual Property; National Institute of Allergy and Infectious Diseases (U.S.)/economics; United States; World Health Organization

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Financing, Government / COVID-19 Vaccines Topics: Vaccines Country/Region as subject: North America Language: English Journal: Clin Pharmacol Ther Year: 2022 Document Type: Article Affiliation country: Cpt.2344

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google